8-KEarnings & ResultsOther EventsExhibits & Filings

METLIFE INC 8-K Report, Financial Results (Nov 1, 2017)

Filed November 1, 2017For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife Inc. (MET) filed an 8-K on November 1, 2017, announcing its third-quarter 2017 financial results and key strategic decisions. The company reported its operational and financial performance for the quarter ended September 30, 2017, with details available in attached exhibits including an Earnings Release, Quarterly Financial Supplement, and Supplemental Slides. Investors should note that these materials are furnished, not filed, meaning they are for informational purposes and don't carry the same regulatory weight as filed documents. Beyond the quarterly results, a significant announcement was the Board of Directors' approval of a new $2 billion authorization for share repurchases. Furthermore, MetLife indicated its intention to divest its remaining stake in Brighthouse Financial, Inc. through an exchange offer of Brighthouse shares for MetLife common stock, anticipated in 2018. This exchange offer is contingent on separate board authorization, market conditions, and regulatory approval, signaling a strategic move to streamline its portfolio and return capital to shareholders.

Key Highlights

  • 1MetLife announced its third-quarter 2017 financial results. Detailed information is provided in accompanying Earnings Release, Quarterly Financial Supplement, and Supplemental Slides.
  • 2The company has secured Board approval for a new $2 billion share repurchase program, indicating a commitment to returning capital to shareholders.
  • 3MetLife intends to divest its remaining common stock in Brighthouse Financial, Inc. during 2018.
  • 4The divestiture of Brighthouse Financial shares will be conducted through an exchange offer for MetLife's common stock.
  • 5The planned exchange offer is subject to market conditions, regulatory approval, and a separate board authorization.
  • 6All financial results and supplemental materials are furnished and not filed, as per standard 8-K procedures.

Frequently Asked Questions

The 8-K filing references MetLife's Earnings Release, Quarterly Financial Supplement, and Supplemental Slides for the quarter ended September 30, 2017, which contain the specific financial results. These detailed documents are attached as exhibits to the 8-K.

The $2 billion authorization indicates MetLife's confidence in its financial position and its commitment to enhancing shareholder value by reducing the number of outstanding shares. This can potentially increase earnings per share.

MetLife intends to sell its remaining shares in Brighthouse Financial, Inc. through an exchange offer in 2018. This means MetLife shareholders will likely have the opportunity to exchange their MetLife shares for Brighthouse shares, or vice versa depending on the offer structure, with the ultimate goal for MetLife to exit its investment in Brighthouse.

The financial results (Earnings Release, Quarterly Financial Supplement, and Supplemental Slides) and the news release regarding the Brighthouse divestiture and share repurchase are furnished to the SEC as part of this 8-K filing, not officially filed. This means they are provided for informational purposes and are not subject to the same liability provisions as formally filed documents.